Braverman’s reappointment highlights double standards over national security says Penman

The FDA has highlighted the double standards of reappointing Suella Braverman as Home Secretary less than a week after being dismissed from the same post for a security breach.
Dave Penman, FDA General Secretary, told Rajeev Syal at the Guardian that “any civil servant who had knowingly shared confidential government information… would face gross misconduct charges and in all likelihood dismissal.” Penman continued that “this is not theoretical” as civil servants have lost their security clearance and been subsequently sacked for deliberately sharing confidential information, as Braverman has admitted doing. “There rightly should be no exceptions when it comes to national security”, argued Penman.
After Braverman made an appearance in the House of Commons to address her dismissal, Penman appeared on ITV News to demonstrate how the Home Secretary’s answers failed to assuage concerns regarding the six times she sent official government documents from her personal email. Speaking to Anushka Asthana, Penman stated that is was “extraordinary that a minister would be… routinely sharing information outside of government” and he insisted that we “can’t have one rule for ministers and one rule for civil servants”.
Related News
-

“An outstanding leader with a proven track record” – FDA responds to Dame Antonia Romeo appointment
The FDA has welcomed the appointment of former Home Office Permanent Secretary Dame Antonia Romeo as Cabinet Secretary, following the departure of Sir Chris Wormald last week.
-

“New low” for government’s relationship with civil service – FDA responds following departure of Cabinet Secretary Chris Wormald
The FDA has responded to the announcement that Sir Chris Wormald has departed the role of Cabinet Secretary, with FDA General Secretary Dave Penman describing it as a “new low” for the government’s relationship with the civil service.
-

“Farcical” to wait until 2030 to make decision on restoration and renewal of parliament, says FDA
The FDA has responded to the latest publication of UK Parliament’s Restoration and Renewal Board, ‘Delivering restoration and renewal of the Palace of Westminster: the costed proposals.’